MCK · 8-K · 20260805PR000232

Market Demand Trends

MCKESSON CORP · 2026-08-05 · Importance 43 · Surprise 32

McKesson’s first-quarter revenues increased 8% to $105.4 billion, driven by higher prescription transaction volumes and distribution of specialty products in the North American Pharmaceutical segment. North American Pharmaceutical revenue rose 5% to $86.8 billion, including increased specialty-product volumes distributed to health systems and strategic accounts. Oncology & Multispecialty revenue grew 33% to $14.2 billion, supported by provider solutions and specialty distribution. Medical-Surgical Solutions revenue increased 4% to $2.8 billion, led by higher specialty-pharmaceutical volumes across alternate sites of care.

Key facts

• First quarter revenues were driven by growth in the North American Pharmaceutical and Oncology & Multispecialty segments due to increased prescription volumes and distribution of specialty products, partially offset by lower contributions from branded pharmaceuticals. source